OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 15:26:16 14/05/2024 BST | ||
| 1.51 EUR | -1.31% |
|
| Current month | +4.08% | ||
| 1 month | +115.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 14/05/24 | 1.51 | -1.31% |
| 13/05/24 | 1.53 | +15.04% |
| 10/05/24 | 1.33 | +2.31% |
| 09/05/24 | 1.3 | +4.84% |
| 08/05/24 | 1.24 | +6.90% |
Real-time BOERSE MUENCHEN
Last update May 14, 2024 at 03:26 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GP53LE |
| ISIN | DE000GP53LE8 |
| Date issued | 30/05/2023 |
| Strike | 124.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.76 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.69 € |
|---|---|
| Lowest since issue | 0.205 € |
| Spread | 0.05 € |
| Spread % | 3.60% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140.8
USD
Average target price
146.7
USD
Spread / Average Target
+4.23%
- Stock Market
- Certificates
- Certificat
